0 Comentários
0 Compartilhamentos
784 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Digital Therapeutics Market Analysis: Growth Drivers, Market Trends and Forecast"Global Executive Summary Digital Therapeutics Market: Size, Share, and Forecast Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. The report has provided crucial information about the...0 Comentários 0 Compartilhamentos 632 Visualizações 0 Anterior
-
Digital Therapeutics market Future Outlook and Growth Potential Report"Digital Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Digital Therapeutics Market Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period...0 Comentários 0 Compartilhamentos 374 Visualizações 0 Anterior
-
Digital Therapeutics Market Research Report: Industry Trends, Demand and Future Outlook"Key Drivers Impacting Executive Summary Digital Therapeutics Market Size and Share Data Bridge Market Research analyses that the global digital therapeutics market which was USD 4,300.00 million in 2022, expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. The Digital Therapeutics Market report contains...0 Comentários 0 Compartilhamentos 485 Visualizações 0 Anterior
-
Lung Transplant Therapeutics Market Growth and Future TrendsLung Transplant Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Transplant Therapeutics Market CAGR Value The global lung transplant therapeutics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the...0 Comentários 0 Compartilhamentos 329 Visualizações 0 Anterior
-
Microbiome-Based Therapeutics Market Forecast: Industry Size, Share, and Future Trends"Global Executive Summary Microbiome-Based Therapeutics Market: Size, Share, and Forecast The global Microbiome-Based Therapeutics market size was valued at USD 3.17 billion in 2024 and is expected to reach USD 18.29 billion by 2032, at a CAGR of 24.50% during the forecast period This Microbiome-Based Therapeutics Market research report contains specific...0 Comentários 0 Compartilhamentos 631 Visualizações 0 Anterior
-
Nucleic Acid-Based Therapeutics Market Outlook: Growth Trends & Market Opportunities"Executive Summary Nucleic Acid-Based Therapeutics Market Size and Share Analysis Report The global nucleic acid-based therapeutics market size was valued at USD 4.94 billion in 2024 and is expected to reach USD 14.38 billion by 2032, at a CAGR of 14.29% during the forecast period This Nucleic Acid-Based Therapeutics Market report is useful in evaluating...0 Comentários 0 Compartilhamentos 614 Visualizações 0 Anterior
-
Rare Pediatric Epilepsy Therapeutics market Competitive Analysis Report for Leading Companies"Rare Pediatric Epilepsy Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Rare Pediatric Epilepsy Therapeutics Market The global rare pediatric epilepsy therapeutics market size was valued at USD 198.00 Million in 2025 and is expected to reach USD 466.90 Million by 2033, at a CAGR of 11.32% during the forecast period The data,...0 Comentários 0 Compartilhamentos 153 Visualizações 0 Anterior
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Dynamics: Key Drivers and Restraints 2025 –2032Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Share, Size & Strategic Insights CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period The key...0 Comentários 0 Compartilhamentos 434 Visualizações 0 Anterior
-
(R)-Homopipecolic Acid Market Projected at USD 52.6M by 2034: Chiral Non-Proteinogenic Amino Acid Unlocks Next-Gen CNS Therapeutics at 7.2% CAGRGlobal (R)-Homopipecolic acid market was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a remarkable CAGR of 7.2% during the forecast period. (R)-Homopipecolic acid is a non-proteinogenic amino acid and a chiral building block characterized by its six-membered nitrogen-containing ring structure. As an...0 Comentários 0 Compartilhamentos 238 Visualizações 0 Anterior
-
(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological TherapeuticsGlobal (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...0 Comentários 0 Compartilhamentos 221 Visualizações 0 Anterior
-
(S)-N-Boc-3-Bromophenylalanine Market Surges to USD 52.7M by 2034 Driven by Peptide Therapeutics BoomGlobal (S)-N-Boc-3-Bromophenylalanine (CAS 82278-73-7) market was valued at USD 28.4 million in 2025 and is projected to reach USD 52.7 million by 2034, exhibiting a remarkable CAGR of 7.3% during the forecast period. (S)-N-Boc-3-Bromophenylalanine (CAS 82278-73-7), a Boc-protected unnatural amino acid derivative featuring a bromine substituent at the meta position of the phenylalanine...0 Comentários 0 Compartilhamentos 224 Visualizações 0 Anterior
-
Adult Malignant Glioma Therapeutics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction Adult malignant gliomas are among the most aggressive and lethal cancers of the central nervous system. Originating in the glial cells of the brain, these tumors are characterized by rapid progression, high recurrence rates, and limited long-term survival outcomes. The most common and severe type, glioblastoma multiforme (GBM), remains extremely challenging to treat, despite...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Adult Malignant Glioma Therapeutics Market Growth Drivers: Share, Value, Size, and Insights"Executive Summary Adult Malignant Glioma Therapeutics Market Research: Share and Size Intelligence Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report makes available the...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Adult Malignant Glioma Therapeutics Market Industry Statistics: Growth, Share, Value, Insights, and Trends"Market Trends Shaping Executive Summary Adult Malignant Glioma Therapeutics Market Size and Share Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report performs geographical...0 Comentários 0 Compartilhamentos 938 Visualizações 0 Anterior
-
Adult Malignant Glioma Therapeutics Market Scope: Growth, Share, Value, Size, and Trends"Executive Summary Adult Malignant Glioma Therapeutics Market Market Size and Share Across Top Segments CAGR Value Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market Market report has...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Adult Malignant Glioma Therapeutics Market: Comprehensive Analysis and Future OutlookIntroduction Adult malignant glioma represents one of the most aggressive and lethal forms of primary brain tumors, posing a significant clinical and economic burden worldwide. Characterized by rapid progression, invasive growth, and limited responsiveness to conventional therapies, malignant gliomas—particularly glioblastoma—continue to challenge oncologists and neuroscientists...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue Analysis Industry Outlook, ForecastAnalysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 Comentários 0 Compartilhamentos 481 Visualizações 0 Anterior
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue, Key Factors, Major Companies, Forecast Analysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 Comentários 0 Compartilhamentos 497 Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek